<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01324687</url>
  </required_header>
  <id_info>
    <org_study_id>31563</org_study_id>
    <secondary_id>R01HS018047</secondary_id>
    <nct_id>NCT01324687</nct_id>
  </id_info>
  <brief_title>Study Of Telemedicine Consultation at Home For Older Adults</brief_title>
  <official_title>Study Of Telemedicine Consultation at Home For Older Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Agency for Healthcare Research and Quality (AHRQ)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Rochester</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The system of medical care for older adults with acute illnesses often serves them poorly.&#xD;
      Many factors limit these patients' access to safe, patient-centered, efficient, high-quality,&#xD;
      acute care. These factors include a shortage of geriatricians and primary care physicians;&#xD;
      limited availability of timely, acute-illness, patient appointments; emergency department&#xD;
      (ED) crowding; interruptions to the continuity of care when patients use the ED; and poor&#xD;
      transitions of care from the ambulatory setting to the ED. These conditions foster&#xD;
      unnecessary ED use, adverse events in the ED for which older adults are particularly at-risk,&#xD;
      and unnecessary medical costs. As the population ages, the magnitude of these problems will&#xD;
      only increase.&#xD;
&#xD;
      The overarching study goals are to develop and evaluate a telemedicine-enhanced care model&#xD;
      that improves access to safe, high-quality, acute illness care for older adults; fosters&#xD;
      appropriate use of health services; and reduces unnecessary expenditures. Specifically, this&#xD;
      study aims to:&#xD;
&#xD;
        1. Expand the existing pediatric HeA telemedicine network to older adults by providing&#xD;
           senior living communities (SLC) with an alternative on-site care option for individuals&#xD;
           with an acute illness episode.&#xD;
&#xD;
           Hypothesis 1: 90% of requested telemedicine visits will be successfully completed.&#xD;
&#xD;
        2. Evaluate the impact of the HeA telemedicine model on utilization, quality of care, and&#xD;
           patient safety.&#xD;
&#xD;
           Hypothesis 2: The rate of ED use will be lower at SLCs with access to care via&#xD;
           telemedicine, as compared to SLCs without such access to care.&#xD;
&#xD;
           Hypothesis 3: Quality of care and patient safety measures will be better for SLC&#xD;
           residents with access to telemedicine-enhanced care than for residents without this form&#xD;
           of access.&#xD;
&#xD;
        3. Evaluate the economic benefit of the care delivered through the telemedicine network.&#xD;
&#xD;
           Hypothesis 4: The net cost of healthcare per patient-month will be less for SLC&#xD;
           residents with access to telemedicine-enhanced care than for those without this form of&#xD;
           access.&#xD;
&#xD;
        4. Use qualitative methods to identify strategies and assets that promote and conditions&#xD;
           that impede the implementation, acceptance, and success of the HeA telemedicine network&#xD;
           in SLCs. This knowledge will inform efforts to develop a toolkit to be used to&#xD;
           disseminate this technology broadly.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Telemedicine is a potential solution with demonstrated effectiveness in other vulnerable&#xD;
      populations. Previous work by members of this research team has shown that telemedicine is an&#xD;
      effective health information technology solution to address similar challenges in multiple&#xD;
      vulnerable populations, demonstrating both improved access to care and reduced ED visits. The&#xD;
      existing telemedicine program in Rochester, Health-e-Access (HeA), has been both successful&#xD;
      and sustained, and well accepted by all key stakeholders including patients, families,&#xD;
      clinicians, and insurers. This existing program, combined with the experience and&#xD;
      multidisciplinary expertise of the investigators research team, creates a unique opportunity&#xD;
      to (1) develop a model of care that leverages this technology to improve geriatric acute&#xD;
      care, (2) evaluate this model through a prospective cohort study, and (3) identify key&#xD;
      barriers and drivers of implementation to promote dissemination.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Emergency Department Use</measure>
    <time_frame>Up to 42 months</time_frame>
    <description>Use of emergency department by individuals with access to care via telemedicine as compared to those without such access to care.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cost of Care</measure>
    <time_frame>Up to 36 months</time_frame>
    <description>Comparison of cost of care between intervention and control groups.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1537</enrollment>
  <condition>Physical Disorders</condition>
  <condition>Telemedicine</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Group without access to telemedicine in the home for acute care issues.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Telemedicine care</arm_group_label>
    <description>Cohort with access to telemedicine in the home for acute care issues.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Telemedicine care</intervention_name>
    <description>Availability of telemedicine</description>
    <arm_group_label>Telemedicine care</arm_group_label>
    <other_name>Telemedicine</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adults residing in senior living communities.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Member of the Strong Health Geriatrics Group practice&#xD;
&#xD;
          -  Consent to participate&#xD;
&#xD;
          -  Resident of facility with telemedicine established&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manish N. Shah, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rochester</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kenneth McConnochie, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rochester</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Rochester</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <study_first_submitted>November 19, 2010</study_first_submitted>
  <study_first_submitted_qc>March 25, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 29, 2011</study_first_posted>
  <results_first_submitted>February 20, 2016</results_first_submitted>
  <results_first_submitted_qc>February 20, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 21, 2016</results_first_posted>
  <last_update_submitted>April 28, 2017</last_update_submitted>
  <last_update_submitted_qc>April 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rochester</investigator_affiliation>
    <investigator_full_name>Manish Shah</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Telemedicine</keyword>
  <keyword>Geriatrics</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>We excluded 15 individuals from analysis because they left the facility and the study less than 1 month after starting, and they were significantly different than the rest of the population. We felt that they has been mistakenly accepted into an independent or assisted living and recognized this and moved out to an alternate level of care.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Control</title>
          <description>Group without access to telemedicine in the home for acute care issues.</description>
        </group>
        <group group_id="P2">
          <title>Telemedicine Care</title>
          <description>Cohort with access to telemedicine in the home for acute care issues.&#xD;
Telemedicine care: Availability of telemedicine</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1058"/>
                <participants group_id="P2" count="494"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1058"/>
                <participants group_id="P2" count="479"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Control</title>
          <description>Group without access to telemedicine in the home for acute care issues.</description>
        </group>
        <group group_id="B2">
          <title>Telemedicine Care</title>
          <description>Cohort with access to telemedicine in the home for acute care issues.&#xD;
Telemedicine care: Availability of telemedicine</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1058"/>
            <count group_id="B2" value="479"/>
            <count group_id="B3" value="1537"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="85" lower_limit="79" upper_limit="90"/>
                    <measurement group_id="B2" value="85" lower_limit="19" upper_limit="89"/>
                    <measurement group_id="B3" value="85" lower_limit="79" upper_limit="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="746"/>
                    <measurement group_id="B2" value="347"/>
                    <measurement group_id="B3" value="1093"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="312"/>
                    <measurement group_id="B2" value="132"/>
                    <measurement group_id="B3" value="444"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="63"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1022"/>
                    <measurement group_id="B2" value="452"/>
                    <measurement group_id="B3" value="1474"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1058"/>
                    <measurement group_id="B2" value="479"/>
                    <measurement group_id="B3" value="1537"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Emergency Department Use</title>
        <description>Use of emergency department by individuals with access to care via telemedicine as compared to those without such access to care.</description>
        <time_frame>Up to 42 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Group without access to telemedicine in the home for acute care issues.</description>
          </group>
          <group group_id="O2">
            <title>Telemedicine Care</title>
            <description>Cohort with access to telemedicine in the home for acute care issues.&#xD;
Telemedicine care: Availability of telemedicine</description>
          </group>
        </group_list>
        <measure>
          <title>Emergency Department Use</title>
          <description>Use of emergency department by individuals with access to care via telemedicine as compared to those without such access to care.</description>
          <units>Emergency dept use rate per person-month</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1058"/>
                <count group_id="O2" value="479"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1050"/>
                    <measurement group_id="O2" value="0.0885"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Rate ratio of ED use rate of the intervention group as compared to the control group.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.017</p_value>
            <method>GEE / Poisson regression models</method>
            <param_type>Rate ratio</param_type>
            <param_value>0.8387</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.7261</ci_lower_limit>
            <ci_upper_limit>0.9689</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cost of Care</title>
        <description>Comparison of cost of care between intervention and control groups.</description>
        <time_frame>Up to 36 months</time_frame>
        <population>The cost data was not available from the Finance Office from Rochester General Hospital or Thompson Hospital so this analysis was not performed.</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Group without access to telemedicine in the home for acute care issues.</description>
          </group>
          <group group_id="O2">
            <title>Telemedicine Care</title>
            <description>Cohort with access to telemedicine in the home for acute care issues.&#xD;
Telemedicine care: Availability of telemedicine</description>
          </group>
        </group_list>
        <measure>
          <title>Cost of Care</title>
          <description>Comparison of cost of care between intervention and control groups.</description>
          <population>The cost data was not available from the Finance Office from Rochester General Hospital or Thompson Hospital so this analysis was not performed.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Control</title>
          <description>Group without access to telemedicine in the home for acute care issues.</description>
        </group>
        <group group_id="E2">
          <title>Telemedicine Care</title>
          <description>Cohort with access to telemedicine in the home for acute care issues.&#xD;
Telemedicine care: Availability of telemedicine</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1058"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="479"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1058"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="479"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Manish N. Shah</name_or_title>
      <organization>University of Rochester</organization>
      <phone>585-276-6565</phone>
      <email>manish_shah@urmc.rochester.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

